Authors


Dr Marc D. de Smet

Latest:

Maintaining quality and safety in retina clinics during a pandemic

To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.


Cheryl Guttman Krader; Reviewed by Dr Geeta Lalwani

Latest:

Investigators find genetic factors may influence diabetic eye disease

Study results, including data from approximately 42,000 eyes, found diabetic retinopathy severity is a risk factor for diabetic eye disease progression. Other findings support the idea that genetic factors may influence the development of proliferative diabetic retinopathy versus diabetic macular oedema.


Artemis Matsou, MD, MRCP(UK), FEBO

Latest:

Racing against microbial keratitis

Challenging choices force ophthalmologists to weigh long-term outcomes


Odette Zero, MD, MSc

Latest:

Making the diagnosis: Bilateral blurry vision in a 9-year-old boy

The child's changes in vision began at school and worsened over the next day to the point where he could see only outlines and shapes of objects.



By Lynda Charters; Reviewed by Mark C. Vital, MD

Latest:

Capsulotomy creation equally safe using the manual or energy-based method

A study demonstrates corneal endothelial cell density measured postoperatively does not differ whether the capsulotomy was performed using continuous curvilinear capsulorhexis (CCC) or precision pulse capsulotomy (PPC)


Dr Michael Greenwood

Latest:

The advantages of incorporating ECP into the surgeon’s armamentarium

The versatile technique comes with short learning curve and combines well with MIGS.


Jordana Joy

Latest:

US FDA issues Complete Response Letter for avacincaptad pegol (Izervay, Astellas Pharma Inc)

The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration


Lynda Charters; Reviewed by Atika Safitri, PhD

Latest:

Ethnic background has an impact on glaucoma outcomes

Gauging patient perceptions in an ethnically diverse UK cohort


Lynda Charters; Reviewed by Neeru Vallabh, MBBS, FRCOphth, PhD

Latest:

Metabolomics and the molecular approach to glaucoma diagnosis

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle



Sydney M Crago

Latest:

The deep dish on all things ophthalmology at this year's AAO meeting

The annual meeting held in Chicago, Illinois, featured new data and best practices for patient-centred care



Dr Ainhoa Molina-Martín

Latest:

The relationship between myopia and conjunctival-scleral geometry

A recent prospective study analysed the relationship between corneo-scleral geometry and the axial length of the eye to develop preliminary prediction models of the axial length of the eye based on clinical data.


Dr Grazia Pertile

Latest:

Role of anterior vitreous, managing retinal folds in retinal detachment cases

Dr Grazia Pertile discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.


Louise Gagnon; Reviewed by Debra Goldstein, MD, FRCSC

Latest:

Imaging trends in paediatric uveitis

OCT methods are invaluable in the assessment of patients with the condition


Prof. Mariya Moosajee

Latest:

Landscape of genetic therapies for USH2A-related retinitis pigmentosa

Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.


Jeremiah Brown Jr, MD

Latest:

Why imaging is key to managing geographic atrophy

Paying attention to high-resolution OCT is more important than ever


Michelle Dalton, ELS; Reviewed by Dr Netan Choudhry

Latest:

Treating vitreous opacities with YAG vitreolysis

Study found that YAG laser vitreolysis was less invasive than pars plana vitrectomy for patients with vitreous opacities.


Lynda Charters; Reviewed by Maria Jose Montero, MD

Latest:

Virtual simulations improve global surgical outcomes

Orbis advances cataract surgery training in low-resource areas with technology


Dr Miorica Bertelli

Latest:

Harnessing the power of light in dry age-related macular degeneration

Photobiomodulation has been demonstrated to improve quality of vision in several patients suffering from dry AMD.


Dr Sandeep Buttan

Latest:

Pilot project aims to overcome inequalities in glaucoma diagnoses

Many low- and middle-income countries lack resources for managing eye health. A pilot project aims to reduce the number of people going blind from untreated glaucoma by raising awareness and increasing engagement with screening and follow-up.


Louise Gagnon

Latest:

Retinal camera unlocks back-of-the-eye secrets

A small study demonstrates that high-resolution imaging with adaptive optics may be a useful method of assessing integrity of the cone mosaic following macular hole repair.


Keith Barton, MD, FRCP, FRCS, FRCOphth

Latest:

Promising avenues could simplify glaucoma management – just in time

Innovative therapies scale up to meet needs of a growing patient population



Matthew L. Lorenz, MD

Latest:

Making the diagnosis: Bilateral blurry vision in a 9-year-old boy

The child's changes in vision began at school and worsened over the next day to the point where he could see only outlines and shapes of objects.



Prof. Christina Grupcheva

Latest:

Navigating COVID-19 with ophthalmic patients in the hospital setting

Experience at one ophthalmic practice in Bulgaria demonstrates that new operating procedures, technologies and good management can enable clinics to remain open and operate safely during the COVID-19 pandemic. Ophthalmic training and education should continue to be a priority.


Chirag Jhaveri, MD

Latest:

Clinical Implications of Port Delivery System in Retinal Diseases

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.


Prof. Robert P Finger

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.

© 2024 MJH Life Sciences

All rights reserved.